Delfina's AI-powered maternal health platform is an end-to-end solution designed to empower birthing people, support care teams, and tackle the maternal health crisis head-on by enabling early intervention, personalized care planning, and culturally competent support throughout the pregnancy and postpartum journey. The company leverages clinically validated machine learning techniques to predict future interventional needs, thereby bridging the maternal health gap and reducing healthcare costs.
Cyborg Score Rationale
Delfina raised $17 million in its Series A round in January 2025, demonstrating strong investor validation. The company was named "Best Maternal Health Platform of 2025" by MedTech Breakthrough, and recognized in CB Insights' 2025 Digital Health 50 as the only maternal health company on the list. The company has scaled rapidly with proven clinical outcomes and expanding partnerships across health plans and providers.
Top Insights
Delfina's platform has demonstrated proven results including reductions in preterm births, NICU admissions, and maternal health complications, ensuring significant cost savings for health plans.
Blue Cross and Blue Shield of Texas expanded Delfina's reach to 30+ OB practices and 2,000+ patients across BCBSTX in-network providers in Texas, marking a two-year partnership.
Delfina has applied machine learning to model hypertensive disorders of pregnancy (winning an award from NICHD), gestational diabetes, small for gestational age, and gestational weight gain.
In partnership with the California Office of the Surgeon General, Delfina launched the Preconception Medical Assessment (PreMA) widget, a clinically-validated, digital tool that helps people identify and act on health risks before pregnancy.
Named Competitors
Babyscripts — Digital maternal health platform focused on remote monitoring and patient engagement
Recent Developments
(January 2025) Completed $17 million Series A funding round led by US Venture Partners (USVP)
(May 2025) Won "Best Maternal Health Platform of 2025" award from MedTech Breakthrough
(2025) Reached 10,000+ patients served milestone and recognized in CB Insights' 2025 Digital Health 50
(2025) Expanded partnerships with Blue Cross Blue Shield of Texas, Maryland health plans, and FQHC networks including Esperanza Health Centers and Legacy Community Health
Open the full interactive Delfina Care Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.